VaccineGuard vaccination certificates, issued through the national patient portal, will comply with the proposed EU green certificate, once deployed, however the platform provides the capabilities to extend greatly the functionality by linking the full supply chain of each individual vaccine to the certificate, enabling rapid root cause analysis in the event of adverse reactions. In the next phase, also Covid tests results and recovery confirmation will be issued from the platform with the same integrity guarantee that the data originates from the legitimate source and process.
The platform enables pharma manufacturers to work with their government and their care provider clients to see through the last mile of the pharmaceutical value chain for real-time stock and supply, counterfeit and diversion detection as well as rapid correlation and root cause analysis of adverse reaction detection.
VaccineGuard provides a distributed data exchange platform for public health authorities, hospitals, citizens, certificate providers, vaccine manufacturers, border guards, and others to share information securely and reliably across systems and borders. It provides a feedback loop between all participants in the network without creating centralized shared databases or ERP systems, while employing leading privacy and security features to protect patient and other sensitive information.
Guardtime is working with multiple manufacturers and numerous governments around the world to see VaccineGuard deployed at scale with a special focus on COVAX facility countries where counterfeit vaccines are a major issue and centralized ERP systems are complex to establish and ultimately fail to deliver value due to the difficulties in sharing data across organizational boundaries.
Kersti Kaljulaid, President of Estonia said:
“As one of the most digitally advanced nations in the world, we are very excited to offer our citizens a trustworthy COVID-19 vaccine certificate, providing another major step on our road back to normality. Online-only meetings are not enough to ensure true connectivity, people also need the freedom to travel for both business and leisure. I am glad Estonia has developed a trustworthy and technically advanced certificate programme. Along with Guardtime, Estonia is keen to share our experience in managing our vaccination programme and the development of our certificate initiative with all interested parties.”Kuuno Vaher, General Manager for Central Europe and Baltics, AstraZeneca said:
“VaccineGuard is a real breakthrough for pharma companies who wish to take advantage of the investments in serialization but lose visibility over products as they exit the end of their existing supply chains. VaccineGuard is an example of innovation brought by the pandemic, providing real-time visibility for product planning and supporting our government clients in counterfeit detection and pharmacovigilance.”Ain Aaviksoo, Chief Medical Officer, Guardtime said:
“This is a very proud moment for us, and we are delighted to have played such a key role in helping the Estonian government with its COVID-19 vaccination programme. Having quality data that is up to date, reliable and easy to share is key to winning the battle against Coronavirus, and VaccineGuard can play a key role in this.”
For more information about VaccineGuard visit guardtime.com/vaccineguardKersti Kaljulaid, President of Estonia